282 related articles for article (PubMed ID: 10119189)
1. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions.
Pearson VE; King LM
Hosp Pharm; 1992 Jul; 27(7):610, 613-4. PubMed ID: 10119189
[TBL] [Abstract][Full Text] [Related]
2. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
Oh T; Franko TG
Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
[TBL] [Abstract][Full Text] [Related]
3. Fiscal impact of a total nutrient admixture program at a pediatric hospital.
Eskew JA
Am J Hosp Pharm; 1987 Jan; 44(1):111-4. PubMed ID: 3103430
[TBL] [Abstract][Full Text] [Related]
4. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
Connelly JF
Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581
[TBL] [Abstract][Full Text] [Related]
5. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
Maswoswe JJ; Newcomer DR; Quandt CM
Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist monitoring of parenteral nutrition: clinical and cost effectiveness.
Mutchie KD; Smith KA; MacKay MW; Marsh C; Juluson D
Am J Hosp Pharm; 1979 Jun; 36(6):785-7. PubMed ID: 111548
[TBL] [Abstract][Full Text] [Related]
7. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
Coppola P
Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
[TBL] [Abstract][Full Text] [Related]
8. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
9. Savings achieved through use of a less concentrated amino acid solution.
Ivey MF; Baluch W; Mueller W
Am J Hosp Pharm; 1979 Jan; 36(1):57-9. PubMed ID: 103434
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a 2-liter plastic container for parenteral nutrient solutions.
Thorn DB; Tanner DJ
Am J Hosp Pharm; 1984 Apr; 41(4):680-5. PubMed ID: 6426298
[TBL] [Abstract][Full Text] [Related]
11. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
12. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
13. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
Segal R; Oh T; Ben-Joseph R; Russell WL
Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
[TBL] [Abstract][Full Text] [Related]
14. Personnel costs and preparation time in a centralized intravenous admixture program.
Ryan DM; Daniels CE; Somani SM
Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist as team leader for total parenteral nutrition therapy.
Greenlaw CW
Am J Hosp Pharm; 1979 May; 36(5):648-50. PubMed ID: 110145
[TBL] [Abstract][Full Text] [Related]
16. Controlling pharmacy costs.
Stansfield S
J Can Diet Assoc; 1988; 49(2):121-3. PubMed ID: 10312527
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and central parenteral nutrition: a cost-comparison analysis.
May J; Sedman P; Mitchell C; MacFie J
Health Trends; 1993-1994; 25(4):129-32. PubMed ID: 10133873
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of formulary restriction demonstrates significant cost savings.
Wetmore RW; Jennings RH
Hosp Formul; 1991 Nov; 26 Suppl D():30-2. PubMed ID: 10136564
[TBL] [Abstract][Full Text] [Related]
19. Stability of ranitidine hydrochloride in total parenteral nutrient solution.
Walker SE; Bayliff CD
Am J Hosp Pharm; 1985 Mar; 42(3):590-2. PubMed ID: 3920904
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections.
Fraher MH; Collins CJ; Bourke J; Phelan D; Lynch M
J Hosp Infect; 2009 Oct; 73(2):129-34. PubMed ID: 19709776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
